update 16th Feb. 2013
PROFILE The INJEX Pharma AG in Berlin GERMANY, is a manufacturer and distributor of innovative and sustainable health solutions. Product focus are currently needlefree injection systems and exclusive agents. In 2012, the goal of INJEX Pharma AG, is to become the first manufacturer of needle free injections accompanied by strong operating profits.
Earlier this year, the company INJEX Pharma AG, established itself on the exchange of German Stock Exchange as well as on XETRA in Frankfurt.
A change in Entry Standard is underway and will be implemented as soon as possible. A securities prospectus will be forthcoming. PRODUCTS
INJEX30, the needle free injection, is the product leader. The strongest applications are the use of local anaesthesia, especially in dentistry, and the administration of insulin for diabetics.
Recently INJEX Pharma has added a new product line in the field of cosmetology & beauty: It has developed its own brand of hyaluronic acid for the removal of wrinkles, called SHIREEN. It is gently administered needlefree using the INJEX jet injection technology.
SHIREEN at the BEAUTY DÜSSELDORF
SHIREEN at the Aesthetics Conference 2013
SHIREEN at the Professional Beauty Show 2013
The list of international distributors is growing rapidly. So far, the strongest regions are in Asia, Australia, South America and the Middle East.
Other large markets in India and China are awaiting their registration approvals by the Ministry of Health.
Sales and marketing in USA begins in June 2012, after INJEX Pharma Berlin and the INJEX Pharma US,
located in Miami, Florida hasreceived FDA clearance for the import and sale of the needle free injection technology INJEX 30 into the US Market
. CAPITAL SHARES:
View chart at German Stock Exchange: http://www.boerse-frankfurt.de/de/aktien/injex+pharma+ag+DE000A0STYL
7 View Master Data at german Stock Exchange
!!!!CHARTS WILL BE AVAILABLE WHEN PROSPECTUS IS READY!!!!
Intraday Frankfurt Stock Exchange Intraday XETRA / Frankfurt
| || |
| || |
|2013 ||Planned General Standard segment change |
| || |
| || |
|Year 2013 || |
|Feb 2013 ||Preliminary Figures fourth quarter 2012 |
|29. April 2013 ||Publication of Annual Report of 2012 |
|20. May 2013 ||Interim Report first quarter of 2013 |
|26. July 2013 ||Shareholder meeting |
|25. August 2013 ||Semi-Annual Report 2013 |
|18. November 2013 ||Interim Release third quarter of 2013 |
All information and graphics taken with kind permission from the website: http://www.injex.com
) and http://www.beauty-shireen.com